Dr. Michael Cooper, MD

Dr. Cooper practices at Staten Island University Hospital - North Campus in Staten Island, New York.

Dr. Cooper's NPI, 1053396655, was assigned on December 7, 2005. Dr. Cooper graduated from JS Weill Medical College, Cornell University in 1990. Dr. Cooper holds New York license 196555.

Dr. Cooper's primary practice is Staten Island University Hospital - North Campus, at 475 Seaview Ave, Staten Island, NY 10305 in Richmond County. The practice phone is (718) 226-4502.

Dr. Cooper's primary practice is Staten Island University Hospital - North Campus in Staten Island, New York. Dr. Cooper is also affiliated with Staten Island University Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Cooper to 2 more home health agencies, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cooper practices, 4 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Cooper's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Cooper is board certified in plastic surgery by the American Board of Plastic Surgery. Dr. Cooper is licensed in New York.

CMS data shows 2,053 Medicare services from Dr. Cooper across 17 procedure codes in 2024, for 368 Medicare patients. Medicare paid $116,222 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 368 Medicare patients who saw Dr. Cooper in 2024. The largest group is 75 to 84, with 127 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 47% are also on Medicaid. Their average risk score is 3.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cooper's median patient age at 68, with 57% women.

In 2024, Dr. Cooper wrote 169 Medicare Part D claims for 98 patients. 88% of them were for generic drugs. CMS names the drug for 94 of them, across 4 drugs with 11 or more claims each, at $638 in total drug cost. In 2023, CMS named 84 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Cooper for performance year 2024, reported through an alternative payment model (APM). Dr. Cooper accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 153 procedures of removal of tissue by Dr. Cooper, more than 89% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 38 papers to Dr. Cooper, published from 2010 to 2025. 2014 was the busiest year, with 5. The most frequent topics are Signal Transduction, Hedgehog Proteins and Isocitrate Dehydrogenase. Dr. Cooper has published most often in PLoS One. Dr. Cooper's most frequent co-authors are Michael K. Cooper, DO, Michael Taylor and Rajeev Vibhakar, MD.

CMS Open Payments shows 25 general payments to Dr. Cooper from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Urgo Medical North America, LLC paid the most, $553.

Dr. Cooper graduated from JS Weill Medical College, Cornell University in 1990.